Vertex
Is this your brand? Claim it — free, and takes a minute with your work email.
Overview
Tagline Brand's website · 2026-10-04
Commitment to scientific innovation to create transformative medicines, pioneering genetic treatments (e.g., first-and-only genetic treatment for SCD and TDT for patients 2 and older), and focus on serious and rare diseases with high unmet needs.
Description Brand's website · 2026-10-04
Vertex is a global biotechnology company that invests in scientific innovation to discover, develop, and produce transformative medicines for people with serious diseases, including cystic fibrosis, sickle cell disease, beta thalassemia, IgA nephropathy, and type 1 diabetes.
Offerings
Core capabilities Brand's website · 2026-10-04
CRISPR-based therapy (Casgevy) for sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT); CFTR modulator therapies for Cystic Fibrosis; investigational treatments for IgA nephropathy and type 1 diabetes (T1D).
Pricing Brand's website · 2026-10-04
Not specified in the provided text, but typical for pharmaceutical products (value-based, prescription-based).
Audience
Target industry Brand's website · 2026-10-04
Patients with serious diseases such as cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia, IgA nephropathy, type 1 diabetes, and APOL1-mediated kidney disease.
Is this your business?
The information above is publicly sourced — assembled by Optimly from Vertex's website and public pages.
Claim this profile to publish your own verified Business Profile and speak for Vertex across the index.
Claim Vertex — free →Page last updated 2026-10-17.